跳至主要内容
临床试验/NCT03121573
NCT03121573已完成不适用

Efficacy and Safety of Duloxetine Among Individuals With Depressive Disorder in a 12 Weeks Trial

Taichung Veterans General Hospital0 个研究点目标入组 30 人开始时间: 2014年12月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
30
主要终点
Change in Depression severity

研究概览

简要总结

The aim of this study was to investigate the effects of duloxetine on improvement of brain cortical activity in patients suffering from major depressive disorder using near infrared spectroscopy.

研究设计

研究类型
Interventional
干预模型
Sequential
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • HAMD-17 more than 12 points
  • Participants could understand this study and sign permit
  • Participants could receive NIRS measurements
  • Participants could comply with the protocol of the study

排除标准

  • alcohol or substance abuse within 3 months of the study
  • ever participate other clinical study related to duloxetine
  • previous poor treatment effects of duloxetine
  • concomitant use of MAOi within 14 days
  • concomitant use of Linezolid
  • with uncontrolled glaucoma

研究组 & 干预措施

intervention

Other

medication: duloxetine 30 to 60 mg tablets by mouth, QD to BID.

干预措施: Duloxetine (Drug)

结局指标

主要结局

Change in Depression severity

时间窗: 0-2-4-8-12 weeks

Hamilton Rating Scale for Depression

次要结局

  • Change in Brain cortical activity(0-2-4-8-12 weeks)

研究者

申办方类型
Other
责任方
Sponsor

相似试验

Efficacy and Safety of Duloxetine Among Individuals... | 临床试验